With Hemlibra, Roche seeks to break into tight hemophilia circle

Swiss drugmaker Roche is breaking into hemophilia A treatment, a $10 billion global market dominated by rivals who have cultivated close ties to sufferers of the genetic bleeding disorder.

Source: Reuters: Health - October 3, 2018 Category: Consumer Health News Tags: healthNews Source Type: news